Meluha Therapeutics Sdn. Bhd. (MTSB) is a clinical-stage biotechnology company which was incorporated on 2nd April 2009, developing novel and proprietary best-in-class therapies intended to extend and enhance the quality of human life.

Our focal point is on researches, develops, manufactures and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. Meluha Therapeutics lead investigational product, CHONDROGEN™ and CHONDROKIN™ which are designed to reconstruct a patient’s own knee cartilage to treat pain at the source and potentially prevent a patient’s progression to osteoarthritis.

We continue to advance our research and development (“R&D”) by focusing on the treatment of medical conditions where there is significant unmet clinical need, and we are particularly focused on developing therapies in the regenerative medicine area.

Meluha Life Sciences is a clinical-stage biotechnology company which was incorporated on 2nd April 2009, developing novel and proprietary best-in-class therapies intended to extend and enhance the quality of human life.

Our focal point is on researches, develops, manufactures and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. Meluha Life Sciences lead investigational product, CHONDROGEN™ and CHONDROKIN™ is designed to reconstruct a patient’s own knee cartilage to treat pain at the source and potentially prevent a patient’s progression to osteoarthritis.

We continue to advance our research and development (“R&D”) by focusing on the treatment of medical conditions where there is significant unmet clinical need, and we are particularly focused on developing therapies in the regenerative medicine area.

Our Team

Muniandy MK Ramansurvey

MSc.

INNOVATION CENTRE MANAGER

Ilakiya Sharanee Kumar

MSc.

HEAD OF QUALITY CONTROL

Mohamad Farzihan

MSc.

QUALITY ASSURANCE SENIOR EXECUTIVE

Nurul Balqis Azman

BSc.

PRODUCTION EXECUTIVE

Agilandeswarie Kavin Selvan

BSc.

PRODUCTION EXECUTIVE

Nur Fahada Syahira

BSc.

QUALITY CONTROL EXECUTIVE

Jennifer Joanne Jugah

BSc.

QUALITY CONTROL EXECUTIVE

Scientific Advisors

MTSB engages scientific advisors to provide advice and guidance on the company’s research and development, as well as improving production capabilities. MTSB advised regularly from our scientific experts. Besides, MTSB has strong influences with numerous experts and key opinion leaders in the fields of cell biology, regenerative medicine and biopharmaceutical development.

DR. REBECCA LIM

Ph.D

ASSOCIATE PROFESSOR (RESEARCH), MONASH HEALTH

Dr. Rebecca Lim has joined our company as a Chief Scientific Advisor. She was awarded her PhD from the University of Western, Australia. The Ritchie Centre is where she leads the Regenerative Medicine and Cellular Therapies Team. She holds a joint appointment with the Department of Obstetrics and Gynaecology, Monash University.

She has been a Chief Investigator on seven federally funded National Health and Medical Research Council grants. She is a CI on two registered cell therapy clinical trials where her basic scientific research is being translated to the bedside. Her research is focused on translating discoveries around

DATO’ DR. BADRUL AKMAL HISHAM MD. YUSOFF

MD (UKM), MS (Ortho), UKM

HEAD OF ARTHROSCOPIC & SPORTS TRAUMA, UKM

Badrul Akmal Hisham Md Yusoff currently works at the Department of Orthopaedics and Traumatology, National University of Malaysia. Dato’ Badrul does research in Sports Medicine, Clinical Trials and Orthopedic Surgery. His current project is ‘Allogenic Stem Cell for knee osteochondral injury’.

DR. AARON LIM

MCh (Ortho), MBBCh, BAO (Hons)

ORTHOPAEDIC SURGEON, ISLAND HOSPITAL

Dr Aaron Lim is a resident orthopaedic and sport injury surgeon in Island Hospital, Penang Malaysia. Dr Aaron Lim has been awarded with Master of Surgery in Orthopaedic, MCh Orth (Liverpool) Gold Medal, Fellow of the Royal College of Surgeons, FRCS (Edinburgh), as well as Academy of Medicine Malaysia, AM.

Board of Directors

Dato’ Dr. Abdul Jalil Jidon

LLB (UKM)

CHAIRMAN

Puan Noor Arlisma Zainul Ariff

MD (UKM), M. Ch. (Gen)

LEGAL ADVISOR

Ramesh Saravanamuthu

MBA

MANAGING DIRECTOR

Karthik Chandran

BSc.(Hons)

COMMERCIAL DIRECTOR

Kuhan Jeganathan

MBA

CHIEF STRATEGY OFFICER (CSO)

Meluha-Logo-RGB-01

MELUHA THERAPEUTICS SDN BHD
Lot 1G & 2G,
Kompleks Lanai,
No.2, Persiaran Seri Perdana,
62250 Putrajaya, Malaysia.

© Meluha Therapeutics